Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genome-wide sequencing of schizophrenia and control individuals [WGS]

ABSTRACT: Genome-wide sequencing of schizophrenia and control individuals [WGS]

PROVIDER: PRJNA422380 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6375930_1.fastq.gz	Fastqsanger.gz
	SRR6375930_2.fastq.gz	Fastqsanger.gz
	SRR6375940_1.fastq.gz	Fastqsanger.gz
	SRR6375940_2.fastq.gz	Fastqsanger.gz
	SRR6375950_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 108

Similar Datasets

Genome-wide sequencing of schizophrenia and control individuals [WGS]

Project description:We carried out whole genome sequencing of 29 schizophrenia patients and 25 control individuals

2019-06-25 | GSE108065 | GEO

Genome-wide binding profiles of nuclear FGFR1 in Control and Schizophrenia hiPSC-dervied NPC [ChIP-seq]

Project description:We report the genome-wide binding patterns of nuclear FGFR1 in Control and Schizophrenia hiPSC-dervied NPC differntiated in neuronal media for two days. We also report the genome-wide binding patterns of NOTCH in schizophrenia hiPSC-dervied NPC differntiated in neuronal media for 2 days

2017-06-01 | GSE92873 | GEO

WTCCC2 Schizophrenia study

Project description:A WTCCC2 project genome-wide case-control association study for schizophrenia (SP) in individuals from Ireland.

| EGAS00000000118 | EGA

Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq]

Project description:We Report the genome-wide RNA expression levels in control and schizophrenia hiPSC dervied NPC treated with neuronal media for 2 days. In total about 15,000 gene expression were detected in all samples, of which 1349 were dysregualted.

2017-06-01 | GSE92874 | GEO

Genome-wide microRNA transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [miRNA-seq]

Project description:We Report the genome-wide RNA expression levels in control and schizophrenia hiPSC dervied NPC treated with neuronal media for 2 days. In total, 440 microRNA expression were detected in all samples, of which 16 were dysregualted.

2017-06-01 | GSE92875 | GEO

Differential H3K9me2 heterochromatin levels and concordant mRNA expression in postmortem brain tissue of individuals with schizophrenia, bipolar, and controls

Project description:The existence of repressive and durable chromatin assemblies along gene promoters or networks, especially in the brain, is of theoretical and therapeutic relevance in a subset of individuals diagnosed with schizophrenia who experience a chronic, persistent, and treatment-resistant trajectory. We used chromatin immunoprecipitation followed by deep sequencing (ChIP-Seq) to generate an epigenomic map that includes differential sites occupied by di-methylated lysine 9 of histone 3 (H3K9me2), a repressive modification that is yet unexplored in human postmortem brain tissue. We have discovered over 150 significantly differential promoter sites in the postmortem prefrontal cortex tissue of individuals diagnosed with schizophrenia (n=15) when compared to controls (n=15). Potentially dysregulated gene categories include postsynaptic proteins, processing enzymes (for proproteins, lipids, and oxidative stress), cadherin family genes, the complement system, and peptide hormones. Ten genes with significantly increased or decreased H3K9me2 promoter occupation were selected through statistical analysis, function, or previous GWAS association, and qRT-PCR was performed on an extended sample of postmortem brain tissue, adding an additional 17 controls, 7 individuals with schizophrenia, and 19 individuals with bipolar samples (n=32 control, 22 schizophrenia, 19 bipolar). This approach revealed that mRNA expression levels correlated with chromatin modification levels in eight of ten selected genes, and mRNA expression in the total sample could be predicted by the occupancy of H3K9me2. Utilization of this method and replication in a larger sample open a pathway to durable and restrictive epigenomic assemblies whose accumulation across the lifespan of individuals diagnosed with schizophrenia may explain treatment resistance, and advance therapeutic options.

2022-10-25 | GSE215991 | GEO

Genome-wide transcriptional analysis of human iPSC-derived healthy control vs. schizophrenia cortical interneurons.

Project description:We report specific changes in schizophrenia developmental interneurons by genome-wide transcriptome analysis.

2019-04-25 | GSE125999 | GEO

Genome-wide transcriptional analysis of human iPSC-derived healthy control vs. schizophrenia cortical interneurons

Project description:We report specific changes in schizophrenia developmental interneurons by genome-wide transcriptome analysis.

2018-10-18 | GSE121376 | GEO

Genome-wide transcriptional analysis of human iPSC-derived healty control vs. schizophrenia cortical interneurons.

Project description:We report down-regulation of protocadeherins in schizophrenia interneurons by genome-wide transcriptome analysis.

2018-11-16 | GSE118313 | GEO

RNA analysis in Finnish Schizophrenia Families

Project description:18 Families (66 individuals) from an established cohort for schizophrenia in Finland provided RNA for analysis of genome-wide gene expression levels in blood lymphocytes. These have been collected for the analysis of genetic risk variants for mental illness that are present within these families, under the hypothesis that genetic variants will lead to changes in the biological functioning that represent the mechanisms altered in the etiology of major mental illness, with gene expression providining a means to observe such alterations. Total RNA was extracted from fresh blood samples donated by 66 individuals from 18 families ascertained for schizophrenia. Gene expression was measured using 6 chips, with two individuals (samples 2 and 8) replicated across chips. The non-normalized matrix contains the complete data, including replicates.

2013-06-19 | E-GEOD-48072 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data